Bille-Brahe N E, Christiansen L A, Damgård Nielsen S A, Jensen S L
Acta Chir Scand Suppl. 1988;547:75-81.
The main complications to peptic ulcer are perforation, stenosis and bleeding. Diagnosis and treatment are discussed with special reference to the principles of 1st Department, Kommunehospitalet, Copenhagen. The three main complications to peptic ulcer disease include perforation, stenosis and bleeding. The etiology to peptic ulcer disease and the pathogenesis of ulcer disease complications are still poorly understood, although an imbalance between mucosa-protecting and -destructing factors seems to be of major importance. However, the introduction of neither H2 receptor antagonists nor the so-called mucosaprotection agents during the seventies and eighties significantly have reduced the frequency of peptic ulcer disease or the frequency of its complications (perforation 10 per cent, stenosis 10 per cent and bleeding 20 per cent of patients with peptic ulcer disease. The unchanged frequency of operation for peptic ulcer complications was confirmed in a recent study by A. Christensen et al. 1987. Their data suggested unchanged frequency of operations for ulcer complications prior to and following the introduction of H2 receptor antagonists (Fig. I and II) in a well defined population in Copenhagen.
消化性溃疡的主要并发症是穿孔、狭窄和出血。本文结合哥本哈根市立医院第一科室的原则对其诊断和治疗进行讨论。消化性溃疡疾病的三大主要并发症包括穿孔、狭窄和出血。尽管黏膜保护和破坏因素之间的失衡似乎至关重要,但目前对消化性溃疡疾病的病因及溃疡病并发症的发病机制仍知之甚少。然而,在20世纪70年代和80年代引入H2受体拮抗剂和所谓的黏膜保护剂后,消化性溃疡疾病的发病率及其并发症的发生率(消化性溃疡病患者中穿孔占10%,狭窄占10%,出血占20%)并未显著降低。A. 克里斯蒂安森等人在1987年的一项最新研究中证实了消化性溃疡并发症手术率未变。他们的数据表明,在哥本哈根一个明确界定的人群中,引入H2受体拮抗剂前后,溃疡并发症的手术率没有变化(图I和图II)。